Figure 6.

Whole-body clinical positron emission tomography images acquired after 60 min post administration of 220 MBq of 18F-fluorodeoxyglucose on discovery image quality 5-ring positron emission tomography/computed tomography system; (a) maximum intensity projection image obtained by VPHD reconstruction technique, arrow shows metastatic axillary lymph node; (b) maximum intensity projection image obtained by Q. Clear reconstruction technique, arrow shows metastatic axillary lymph node (better lesion delineation); (c) transaxial image of the same patient obtained by VPHD reconstruction technique, arrow shows two metastatic auxiliary nodes; (d) transaxial image of the same patient obtained by Q. Clear reconstruction technique, arrow shows two metastatic auxiliary nodes (better lesion delineation)